Philadelphia CyberKnife Continues Trailblazing Cancer Research

HAVERTOWN, Pa. (PRWEB) February 21, 2013

Philadelphia CyberKnife physicians are set this week to present innovative research findings demonstrating the effectiveness of stereotactic body radiation therapy for treating primary and recurrent lung cancer.

Two studies will be presented Feb. 22 at the Radiosurgery Societys 2013 SRS/SBRT Scientific Meeting in California. These are the latest studies from Philadelphia CyberKnife, which has carved a niche for trailblazing clinical research focused on stereotactic body radiation therapy. CyberKnife

Leave a Reply